Literature DB >> 12180926

Type 1 fimbriae and extracellular polysaccharides are preeminent uropathogenic Escherichia coli virulence determinants in the murine urinary tract.

Farah K Bahrani-Mougeot1, Eric L Buckles, C V Lockatell, J R Hebel, D E Johnson, C M Tang, M S Donnenberg.   

Abstract

Escherichia coli is the leading cause of urinary tract infections (UTIs). Despite the association of numerous bacterial factors with uropathogenic E. coli (UPEC), few such factors have been proved to be required for UTI in animal models. Previous investigations of urovirulence factors have relied on prior identification of phenotypic characteristics. We used signature-tagged mutagenesis (STM) in an unbiased effort to identify genes that are essential for UPEC survival within the murine urinary tract. A library of 2049 transposon mutants of the prototypic UPEC strain CFT073 was constructed using mini-Tn5km2 carrying 92 unique tags and screened in a murine model of ascending UTI. After initial screening followed by confirmation in co-infection experiments, 19 survival-defective mutants were identified. These mutants were recovered in numbers 101- to 106-fold less than the wild type in the bladder, kidneys or urine or at more than one site. The transposon junctions from each attenuated mutant were sequenced and analysed. Mutations were found in: (i) the type 1 fimbrial operon; (ii) genes involved in the biosyn-thesis of extracellular polysaccharides including group I capsule, group II capsule and enterobacterial common antigen; (iii) genes involved in metabolic pathways; and (iv) genes with unknown function. Five of the genes identified are absent from the genome of the E. coli K-12 strain. Mutations in type 1 fimbrial genes resulted in severely attenuated colonization, even in the case of a mutant with an insertion upstream of the fim operon that affected the rate of fimbrial switching from the 'off' to the 'on' phase. Three mutants had insertions in a new type II capsule biosynthesis locus on a pathogenicity island and were impaired in the production of capsule in vivo. An additional mutant with an insertion in wecE was unable to synthesize enterobacterial common antigen. These results confirm the pre-eminence of type 1 fimbriae, establish the importance of extracellular polysaccharides in the pathogenesis of UTI and identify new urovirulence determinants.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12180926     DOI: 10.1046/j.1365-2958.2002.03078.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  102 in total

1.  Decreased expression of type 1 fimbriae by a pst mutant of uropathogenic Escherichia coli reduces urinary tract infection.

Authors:  Sébastien Crépin; Sébastien Houle; Marie-Ève Charbonneau; Michaël Mourez; Josée Harel; Charles M Dozois
Journal:  Infect Immun       Date:  2012-06-04       Impact factor: 3.441

Review 2.  Host-pathogen checkpoints and population bottlenecks in persistent and intracellular uropathogenic Escherichia coli bladder infection.

Authors:  Thomas J Hannan; Makrina Totsika; Kylie J Mansfield; Kate H Moore; Mark A Schembri; Scott J Hultgren
Journal:  FEMS Microbiol Rev       Date:  2012-05       Impact factor: 16.408

3.  The Rcs signal transduction pathway is triggered by enterobacterial common antigen structure alterations in Serratia marcescens.

Authors:  María E Castelli; Eleonora García Véscovi
Journal:  J Bacteriol       Date:  2010-10-22       Impact factor: 3.490

4.  The Product of the fimI gene is necessary for Escherichia coli type 1 pilus biosynthesis.

Authors:  Mary L Valenski; Sandra L Harris; Patricia A Spears; John R Horton; Paul E Orndorff
Journal:  J Bacteriol       Date:  2003-08       Impact factor: 3.490

5.  Escherichia coli CFT073 Fitness Factors during Urinary Tract Infection: Identification Using an Ordered Transposon Library.

Authors:  Allyson E Shea; Juan Marzoa; Stephanie D Himpsl; Sara N Smith; Lili Zhao; Lisa Tran; Harry L T Mobley
Journal:  Appl Environ Microbiol       Date:  2020-06-17       Impact factor: 4.792

6.  Evaluation of CpxRA as a Therapeutic Target for Uropathogenic Escherichia coli Infections.

Authors:  Lana Dbeibo; Julia J van Rensburg; Sara N Smith; Kate R Fortney; Dharanesh Gangaiah; Hongyu Gao; Juan Marzoa; Yunlong Liu; Harry L T Mobley; Stanley M Spinola
Journal:  Infect Immun       Date:  2018-02-20       Impact factor: 3.441

7.  In vivo gene expression analysis identifies genes required for enhanced colonization of the mouse urinary tract by uropathogenic Escherichia coli strain CFT073 dsdA.

Authors:  Brian J Haugen; Shahaireen Pellett; Peter Redford; Holly L Hamilton; Paula L Roesch; Rodney A Welch
Journal:  Infect Immun       Date:  2006-10-30       Impact factor: 3.441

8.  Enterobacterial common antigen integrity is a checkpoint for flagellar biogenesis in Serratia marcescens.

Authors:  María E Castelli; Griselda V Fedrigo; Ana L Clementín; M Verónica Ielmini; Mario F Feldman; Eleonora García Véscovi
Journal:  J Bacteriol       Date:  2007-11-02       Impact factor: 3.490

9.  Polysaccharide capsule and sialic acid-mediated regulation promote biofilm-like intracellular bacterial communities during cystitis.

Authors:  Gregory G Anderson; Carlos C Goller; Sheryl Justice; Scott J Hultgren; Patrick C Seed
Journal:  Infect Immun       Date:  2010-01-19       Impact factor: 3.441

10.  The pathogenicity island-associated K15 capsule determinant exhibits a novel genetic structure and correlates with virulence in uropathogenic Escherichia coli strain 536.

Authors:  György Schneider; Ulrich Dobrindt; Holger Brüggemann; Gábor Nagy; Britta Janke; Gabriele Blum-Oehler; Carmen Buchrieser; Gerhard Gottschalk; Levente Emödy; Jörg Hacker
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.